Which compounded GLP-1 providers use licensed US pharmacies?

Short answer: many telehealth vendors that offer compounded GLP‑1 injections partner with licensed U.S. compounding pharmacies — but the exact pharmacy varies by vendor. Before you buy, ask the vendor which pharmacy will fill your script and verify that pharmacy’s state license and sterile‑compounding credentials.

Reputable U.S. compounding pharmacies commonly used for peptide/GLP‑1 compounds (examples you can ask about)

• Wedgewood Pharmacy (Wedgewood Compounding Pharmacy) — large national compounding outfit with sterile injectable experience and a long track record supplying telehealth partners.
• Fagron USA — an international compounding company with licensed U.S. facilities that provide sterile compounding for peptides and injectables.
• Empower Pharmacy — a U.S. compounding pharmacy known for sterile compounding of peptides and hormones and distribution to telehealth providers.

Why I’m naming these: they are established U.S. compounding organizations with documented sterile‑compounding operations and histories of supplying telehealth/clinics. That doesn’t automatically make every compounded product safe, so you should still verify the specific pharmacy and product batch.

How to verify a provider uses a licensed U.S. pharmacy (do this before ordering)

1. Ask the vendor: “What is the pharmacy name, address, and phone number that will fill my prescription?”
2. Check the state board of pharmacy where the pharmacy is located to confirm an active license.
3. Ask whether the pharmacy performs sterile compounding for injectables and whether it follows USP <797>/<800> standards and/or holds third‑party accreditation (URAC, ACHC or PCAB where applicable).
4. Ask if they provide lot/batch testing or sterility testing for the product and what ingredients (source of peptide) are used.
5. Prefer products dispensed by a pharmacist from a U.S.‑licensed pharmacy rather than from an unknown overseas supplier.

Safety note: compounded GLP‑1 peptides (semaglutide, tirzepatide analogs, etc.) are not FDA‑approved as compounded preparations; they can carry extra risks (contamination, variable potency). When possible, discuss FDA‑approved branded options with your clinician.

If you have a particular telehealth vendor in mind, tell me the name and I can help check whether they publicly disclose the U.S. pharmacy they use and how to verify its license.